0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy

Buy Now

History of Research on Tumor Angiogenesis (Hardcover, 2009 ed.) Loot Price: R4,420
Discovery Miles 44 200
History of Research on Tumor Angiogenesis (Hardcover, 2009 ed.): Domenico Ribatti

History of Research on Tumor Angiogenesis (Hardcover, 2009 ed.)

Domenico Ribatti

 (sign in to rate)
Loot Price R4,420 Discovery Miles 44 200 | Repayment Terms: R414 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

In 1971, J. Folkman published in the New England Journal of Medicine a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept that tumors probably secrete diffusible molecules that could stimulate the growth of new blood vessels toward the tumor and that the resulting tumor neovascularization could conceivably be prevented or interrupted by angiogenesis inhibitors. Solid and haematological tumors consist of an avascular and a subsequent vascular phase. Assuming that this depends on the release of angiogenic factors, acquisition of angiogenic capability can be seen as an expression of progression from neoplastic transformation to tumor growth and metastasis.

Beginning in the 1980 s, the biopharmaceutical industry began exploiting the field of antiangiogenesis for creating new therapeutic compounds for modulating new blood vessels in tumor growth. In 2004, Avastin (Bevacizumab), a humanized anti-VEGF monoclonal antibody, was the first angiogenesis inhibitor approved by the Food and Drug Administration for the treatment of colorectal cancer. At present, it has been estimated that over 20,000 cancer patients worldwide have received experimental form of antiangiogenic therapy.

This book offers a historical account of the relevant literature. It also emphasizes the crucial and paradigmatic role of angiogenesis as a biological process and the significance of antiangiogenic approach for the treatment of tumors."

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: 2009
First published: 2009
Authors: Domenico Ribatti
Dimensions: 235 x 156 x 9mm (L x W x T)
Format: Hardcover
Pages: 126
Edition: 2009 ed.
ISBN-13: 978-1-4020-9559-7
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
Promotions
LSN: 1-4020-9559-7
Barcode: 9781402095597

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R62,178 Discovery Miles 621 780
Nanotechnology Applications for Cancer…
Sanyog Jain, Kaisar Raza, … Paperback R4,312 Discovery Miles 43 120
Viral, Parasitic, Bacterial, and Fungal…
Debasis Bagchi, Amitava Das, … Paperback R3,647 Discovery Miles 36 470
The University of Cancer - No One…
James Perry Hardcover R575 Discovery Miles 5 750
Mitigation of Cancer Therapy…
Raj Nair, Rene-Jean Bensadoun Hardcover R3,070 Discovery Miles 30 700
Handbook of Drug Therapy
Horace Dawson Hardcover R3,303 R2,990 Discovery Miles 29 900
Epigenetic Regulation in Overcoming…
Chunfu Wu, Lihui Wang Hardcover R3,700 Discovery Miles 37 000
Visceral Leishmaniasis - Therapeutics…
Awanish Kumar Paperback R3,686 Discovery Miles 36 860
Overcomer
Melanie Cortijo Hardcover R583 Discovery Miles 5 830
Healthy Through Hodgkin's - How one…
Kylene Terhune Hardcover R729 R678 Discovery Miles 6 780
Advances in Cancer Research, Volume 96…
George F. Vande Woude, George Klein Hardcover R3,853 Discovery Miles 38 530
Anticancer Drug Development
Bruce C. Baguley, David J. Kerr Hardcover R3,181 Discovery Miles 31 810

See more

Partners